KETESSE sol inj 50 mg/2ml 20 amp 2 ml

7680560590048 CH-56059 M01AE17 07.10.1.
KETESSE sol inj 50 mg/2ml 20 amp 2 ml
KETESSE sol inj 50 mg/2ml 20 amp 2 ml
KETESSE sol inj 50 mg/2ml 20 amp 2 ml
1 / 3
google

Details

Product number
5605901
CPT
-
Packaging group
20
Unit
Ampulle(n)
Composition
dexketoprofenum 50 mg ut dexketoprofenum trometamolum 73.8 mg, ethanolum 200 mg, natrii chloridum, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 2 ml corresp. natrium 3.15 mg.

Articles (1)

Ketesse, Injektions-/Infusionslösung
Ampullen
20
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
13/10/2025
Professional SmPC
Français
13/10/2025
Professional SmPC
Italien
13/10/2025

Detailed composition

Substance Quantity Type Category
(N/A)
50.0 MG Substance Wirkstoff (Principe actif)
(N/A)
73.8 MG Substance WIZUS
(N/A)
200.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
3.15 MG Substance HBESI

Reimbursement information

Public price
CHF 31.20
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/06/2020

Authorization holder

A. Menarini GmbH

8050 Zürich

Authorization information

Swissmedic authorization number
56059
Drug name
Ketesse, Injektions-/Infusionslösung
Galenic form
LSPA
ATC Code
M01AE17
Authorization status
Z
Dispensation category
B
First authorization
28/05/2004
Authorization expiration date
31/12/9999
IT number
07.10.1.
Domain
Human medicine
Field of application
Nichtsteroidales Analgetikum/Antirheumatikum

Packaging details

Description (FR)
KETESSE sol inj 50 mg/2ml 20 amp 2 ml
Description (DE)
KETESSE Inj Lös 50 mg/2ml 20 Amp 2 ml
Market launch
28/05/2004
Narcotic (BTM)
No

Other packaging sizes

KETESSE sol inj 50 mg/2ml 5 amp 2 ml
5 AMP
View